Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.
Santen
R J
RJ
University of Virginia Health System, Departments of Medicine, Charlottesville, Virginia 22908, USA.
Pinkerton
J
J
McCartney
C
C
Petroni
G R
GR
D001943:Breast Neoplasms / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D011372:Progestins / Q000009:adverse effects*; D012307:Risk Factors
D004967:Estrogens; D011372:Progestins